AlleyWatch Funding· AlleyWatch·· 9 days agoTop DealsAI Score65
Polyphron Raises $20M Seed Led by Quiet Capital to Predict Drug Toxicity in Human Tissue
Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Before Clinical Trials
AI Overview
Polyphron raised $20M in seed funding led by Quiet Capital, with Haystack, Gradient and Compound participating. The New York company grows donor-defined human tissue in an automated lab.
Why it matters
The interview details how Polyphron pairs lab-grown human tissue with longitudinal data to train predictive models, a concrete look at the tissue-as-verification layer for drug testing.
Source:AlleyWatch Funding · alleywatch.com